China, AstraZeneca

China Has Detained a Senior AstraZeneca Executive
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees, the drugmaker says.
Probe of AstraZeneca executive in China raises questions about company’s tactics
China's investigation of AstraZeneca's top executive in the country is raising questions about the company's tactics there.
AstraZeneca updates on China investigations
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China.
AstraZeneca Shares Slide As Execs in China Face Fraud Investigation
Key Takeaways AstraZeneca shares declined Tuesday after reports that senior executives in China were potentially implicated in an insurance fraud case.AstraZeneca China President Leon Wang is cooperating with Chinese authorities,
AstraZeneca’s Stock Price Takes a Hit as China Chief Investigated for Insurance Fraud
BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” to AstraZeneca, but contends that the share selloff is “overdone” and likely a knee-jerk reaction by investors.
AstraZeneca says its China operations president under investigation
AstraZeneca said its China president Leon Wang is under investigation and the drugmaker would cooperate with Chinese authorities.
AstraZeneca Says Current, Former Executives Involved in China Probe
Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe into alleged breaches of laws around drug importation and data privacy, the company said.
AstraZeneca falls on reports of Chinese probe
Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of senior executives in the company's China subsidiary have been implicated in an insurance fraud case.
AstraZeneca's China chief in custody, believes unrelated to insurance probe
AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not know the reason, it did not believe it was linked to a large health insurance fraud case involving the company.
AstraZeneca shares crash 8.4% as China probe widens: Beijing steps up fraud investigation
Astra saw £14.4bn wiped off its value after Chinese media said dozens of managers were implicated in a scandal.
The Central Virginian59m
Pharma giant AstraZeneca says China chief detained
Pharmaceutical giant AstraZeneca said Thursday that the head of its China operations had been detained, after reports the ...
FiercePharma2d
UPDATED: AstraZeneca stock tanks over fears of expanding China fraud probe
AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...
London South East8h
TOP NEWS: AstraZeneca says China chief detained as under investigation
(Alliance News) - AstraZeneca PLC said Thursday that the head of its China operations had been detained, after reports the firm was under investigation for potentially illegal data collection and ...
Why Is AstraZeneca Stock Sinking On Tuesday?
Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...
STAT19h
AstraZeneca says China has detained a senior executive
The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...
China fright ups the stakes for AstraZeneca
China is AstraZeneca ’s second-biggest individual market by sales, accounting for about 13 per cent, although its business there tends to be lower margin than in other geographies. Its issues in China ...